Philip P. Boudreau - 23 Apr 2026 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Apr 2026, 17:34:47 UTC
Prior SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Philip P. Boudreau by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Philip P. Boudreau filed Form 4 for ABBOTT LABORATORIES (ABT) on 27 Apr 2026.

Key facts

  • This page summarizes Philip P. Boudreau's Form 4 filing for ABBOTT LABORATORIES (ABT).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Apr 2026, 17:34.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: +$201,300.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001805099 Primary reporting owner

Boudreau Philip P

Relationship
EVP AND CFO
Address
100 ABBOTT PARK ROAD, ABBOTT PARK
Signature
/s/ Philip P. Boudreau by Jessica H. Paik, Attorney-in-Fact
Signature date
27 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities

Transaction value
Shares
+8,909
Change %
+2428%
Price
$92.04*
Shares after
9,276
Date
23 Apr 2026
Ownership
Profit Sharing Trust
Footnotes
F1
ABT transaction

Common shares without par value

Purchase

Transaction value
$201,300
Shares
+2,200
Change %
Price
$91.50
Shares after
2,200
Date
23 Apr 2026
Ownership
By Spouse
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
71,172
Date
23 Apr 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .